| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.2B | $8.7B | $9.2B | $10.4B | $9.4B | $2.3B | $2.3B | $1.7B |
| Cost of Revenue | $6.5B | $6.9B | $7.5B | $8.8B | $8.0B | $1.9B | $2.0B | $1.5B |
| Gross Profit | $1.8B | $1.8B | $1.7B | $1.6B | $1.4B | $0.3B | $0.3B | $0.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.4B | $1.3B | $1.2B | $1.2B | $1.1B | $0.3B | $0.3B | $0.2B |
| Operating Income | $0.3B | $0.4B | $0.4B | $0.4B | $0.3B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.2B | $0.2B | $0.3B | $0.3B | $0.2B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $5.00 | $7.73 | $8.53 | $2.24 | $6.27 | $1.52 | $1.22 | $1.33 |
| EPS (Diluted) | $4.86 | $6.55 | $7.55 | $2.13 | $5.95 | $1.50 | $1.20 | $1.31 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.1B | $7.4B | $6.3B | $5.1B | $4.7B | $4.3B | $4.2B | $2.8B |
| Current Assets | $6.4B | $4.8B | $4.3B | $3.9B | $3.6B | $3.2B | $3.0B | $2.3B |
| Cash & Equivalents | $0.4B | $0.3B | $0.3B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $7.4B | $5.7B | $4.6B | $3.5B | $3.2B | $3.0B | $3.0B | $1.8B |
| Current Liabilities | $5.1B | $4.1B | $3.4B | $2.9B | $2.5B | $2.2B | $1.9B | $1.5B |
| Stockholders' Equity | $1.6B | $1.8B | $1.7B | $1.6B | $1.5B | $1.3B | $1.2B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.6B | $0.6B | $0.1B | $0.2B | $0.4B | $0.1B | $0.3B |
| Investing Cash Flow | $-0.3B | $-0.3B | $-0.5B | $-0.1B | $-0.0B | $0.0B | $-0.7B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B |
| Financing Cash Flow | $0.1B | $-0.3B | $-0.0B | $0.1B | $-0.2B | $-0.4B | $0.6B | $-0.2B |